ABSTRACT

Aim:

The aim of study was to retrospectively examine the files of patients operated on for Bethesda category III thyroid nodules, to evaluate the criteria that were taken into consideration for surgical decisions, and predictive factors for malignancy.

Methods:

Patients, who underwent surgery for Bethesda category III thyroid nodules based on preoperative fine-needle aspiration biopsy (FNAB) results between 2014 and 2019 in our clinic, were analyzed retrospectively.

Results:

Of the 90 patients included in the study, 18 (20%) were male and 72 (80%) were female, and the mean age was 48.39±12.96 years (18-84). The mean nodule diameter was 23.67±11.49 mm (6-55). The results of FNAB were atypia of undetermined significance in 80 (88.89%) and follicular lesion of undetermined significance in 10 (11.11%) patients. The most common benign postoperative pathology was nodular hyperplasia in 26 (42.22%) and the most common malignant pathology was papillary thyroid carcinoma in 33 (36.67%) patients. Complementary thyroidectomy was performed in 19 (26.02%) of 26 (35.61%) patients after lobeistmectomy and seven (9.59%) were followed up. In the logistic regression analysis of determinants/risk factors for malignancy, microcalcification and edge irregularity were found to be the most significant factors (p=0.009, p<0.001 and p<0.001, respectively).

Conclusion:

The Bethesda classification used in thyroid nodules continues to pose a dilemma for many surgeons. In patients with Bethesda III nodules, family history, ultrasonography findings (microcalcification, edge irregularity, the nature and number of nodules in the other lobe), and patient and surgeon preference should be taken into consideration when making a decision for surgery.

References

1Eken H, Kurnaz E, Balci MG, Arslan MK. Tiroit İnce İğne Aspirasyon Biyopsi Sonucu Önemi Belirsiz Atipi Olan Olguların Ameliyat Materyalleri Sonuçları ile Karşılaştırmalı Değerlendirilmesi. Med J Bakirkoy 2019;15:240-3.

2Rosário PW, Ward LS, Carvalho GA, et al. Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus. Arq Bras Endocrinol Metabol 2013;57:240-64.

3Jena A, Patnayak R, Prakash J, Sachan A, Suresh V, Lakshmi AY. Malignancy in solitary thyroid nodule: A clinicoradiopathological evaluation. Indian J Endocrinol Metab 2015;19:498-503.

4Gharib H. Current evaluation of thyroid nodules. Trends Endocrinol Metab 1994;5:365-9.

5Hamberger B, Gharib H, Melton LJ III, Goellner JR, Zinsmeister AR. Fine-needle aspiration biopsy of thyroid nodules: impact on thyroid practice and cost of care. Am J Med 1982;73:381-4.

6Block MA, Miller JM, Kini SR. The potential impact of needle biopsy on surgery for thyroid nodules. World J Surg 1980;4:737-41.

7Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2009;19:1159-65.

8Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology.Thyroid 2017;27:1341-6.

9Baloch ZW, Sack MJ, Yu GH, Livolsi VA, Gupta PK. Fine-needle aspiration of thyroid: an institutional experience. Thyroid 1998;8:565-9.

10Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid: a 12-year experience with 11,000 biopsies. Clin Lab Med 1993;13:699-709.

11Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 2008;5:6.

12Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive sum mary of recommendations. Endocr Pract 2010;16:468-75.

13Bongiovanni M, Crippa S, Baloch Z, et al. Comparison of 5-tiered and 6-tiered diagnostic sys- tems for the reporting of thyroid cytopathology: a multi-institutional study. Cancer Cytopathol 2012;120:117-25.

14Ryu YJ, Jung YS, Yoon HC, et al. Atypia of undetermined significance on thyroid fine needle aspiration: surgical outcome and risk factors for malignancy. Ann Surg Treat Res 2014;86:109-14.

15Çakır B, Bilginer MC, Özdemir D, et al. Hemithyroidectomy Seems to be a Reasonable Initial Surgical Approach in Bethesda Category III. Turk J Endocrinol Metab 2018;22:57-63.

16Vanderlaan PA, Marqusee E, Krane JF. Clinical out- come for atypia of undetermined significance in thy- roid fine-needle aspirations: should repeated fna be the preferred initial approach? Am J Clin Pathol 2011;135:770-5.

17Chehade JM, Silverberg AB, Kim J, Case C, Mooradian AD. Role of repeated fine-needle aspiration of thyroid nodules with benign cytologic features. Endocr Pract 2001;7:237-43.

18Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thy- roid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1-133.

19Tai P, Mould RF, Prysyazhnyuk AY, Gristchenko VG, Obodovsky IA. Descriptive epidemiology of thyroid carcinoma. Current Oncology 2003;10:54-65.

20Tyler DS, Winchester DJ, Caraway NP, Hickey RC, Evans DB. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery 1994;116:1054-60.

21Rago T, Di Coscio G, Basolo F, et al. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin Endocrinol (Oxf) 2007;66:13-20.

22Sippel RS, Elaraj DM, Khanafshar E, Kebebew E, Duh QY, Clark OH. Does the presence of additional thyroid nodules on ultrasound alter the risk of malignancy in patients with a follicular neoplasm of the thyroid? Surgery 2007;142:851-7.

23Duran CS, Saraydaroglu O, Ersoy C, et al. Tumor size predictive for malignancy in indeterminate follicular thyroid lesions. Endocrinologist 2006;16:313-6.

24Levine RA. Value of Doppler ultrasonography in management of patients with follicular thyroid biopsy specimens. Endocr Pract 2006;12:270-4.

25Frates MC, Benson CB, Doubilet PM, et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 2006;91:3411-7.

26Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002;87:1941-6.

27Ibrahim B, Forest VI, Hier M, Mlynarek AM, Caglar D, Payne RJ. Completion thyroidectomy: predicting bilateral disease. J Otolaryngol Head Neck Surg 2015;44:23.

28Pacini F, Elisei R, Capezzone M, Miccoli P, Molinaro E, Basolo F, Agate L, Bottici V, Raffaelli M, Pinchera A. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 2001;11:877-81.

29Kim ES, Kim TY, Koh JM, Kim YI, Hong SJ, Kim WB, Shong YK. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilat- eral operation. Clin Endocrinol (Oxf) 2004;61:145-8.

30Donatini G, Castagnet M, Desurmont T, Rudolph N, Othman D, Kraimps JL. Partial thyroidectomy for papillary thyroid microcarcinoma: is completion total thyroidectomy indicated? World J Surg 2016;40:510-5.

31Osmólski A, Frenkiel Z, Osmólski R. Complications in surgical treatment of thyroid diseases. Otolaryn- gol Pol 2006;60:165-70.

32Posillico SE, Wilhelm SM, McHenry CR. The utility of frozen section examination for determining the ex- tent of thyroidectomy in patients with a thyroid nod- ule and “atypia/follicular lesion of undetermined significance.” Am J Surg 2015;209:552-6.

What Should Be Considered in Bethesda III Thyroid Nodules When Prefering Hemitioidectomy or Total Thyroidectomy

ABSTRACT

References